Related Experiment Videos
Serratia odorifera biogroup I: an emerging pathogen
1Department of Medicine, Sisters of Charity Medical Center, Staten Island, NY, USA.
The Journal of the American Osteopathic Association
|October 24, 1998
Summary
Serratia odorifera biogroup 1 can cause serious bloodstream infections (sepsis) in hospitalized patients, challenging previous assumptions about its role as a pathogen. This study confirms its capacity to induce invasive disease, impacting patient outcomes.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Bacteriology
Background:
- Gram-negative bacteremia poses a significant threat in hospital settings.
- Serratia sepsis contributes to substantial patient morbidity and mortality.
- Serratia marcescens is the most frequently implicated Serratia species in human infections.
Observation:
- Clinicians have questioned the pathogenicity of Serratia odorifera biogroup 1 due to limited association with invasive disease.
- Previous literature documented 12 cases of sepsis caused by Serratia odorifera biogroup 1.
- This study consolidates evidence regarding the clinical significance of this organism.
Findings:
- Serratia odorifera biogroup 1 is confirmed as a human pathogen capable of causing sepsis.
- The findings challenge the notion that Serratia odorifera biogroup 1 is solely a commensal or non-pathogenic organism.
- This research solidifies the understanding of Serratia species' diverse roles in healthcare-associated infections.
Implications:
- Healthcare providers should consider Serratia odorifera biogroup 1 in the differential diagnosis of Gram-negative sepsis.
- Enhanced surveillance and diagnostic strategies may be needed to identify infections caused by this pathogen.
- This study contributes to a more comprehensive understanding of Serratia-related sepsis and its clinical management.